Andrew Bogorad
About Andrew Bogorad
Andrew Bogorad serves as the Head of Special Projects, Investments at Roivant Sciences, a position he has held since 2022. He has extensive experience in operations and management within the life sciences sector, having previously worked at Aruvant and Roivant Sciences in various leadership roles.
Current Role at Roivant Sciences
Andrew Bogorad serves as the Head of Special Projects, Investments at Roivant Sciences. He has held this position since 2022 and operates within the New York City Metropolitan Area. In this role, he is responsible for overseeing various special projects and investment initiatives, contributing to the strategic direction of the organization.
Previous Experience at Aruvant
Prior to his current role, Bogorad worked at Aruvant as the Head of Operations from 2019 to 2022. During his three-year tenure, he managed operational strategies and processes, enhancing the efficiency of the organization.
Experience at Roivant Sciences
Before his current position, Bogorad was Chief of Staff to the President of Roivant Pharma from 2017 to 2019. His responsibilities included supporting executive leadership and facilitating communication across departments. He also briefly served as Head of Operations at Roivant Pharma for three months in 2019.
Educational Background
Bogorad earned a Ph.D. in Biophysics from Boston University, where he studied from 2011 to 2016. He also holds a Master of Engineering in Biomedical Engineering from Cornell University and a Bachelor of Arts in Physics with a minor in Biophysics and Finance from Princeton University.
Consulting and Teaching Experience
In addition to his roles in industry, Bogorad has experience in academia. He worked as a Postdoctoral Associate at Boston University School of Medicine for seven months in 2017. He also served as a Teaching Fellow in Graduate Medical Sciences at Boston University from 2014 to 2015 and as a Technology Development Analyst at the Boston University Office of Technology Development from 2013 to 2015.